TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
STOK

Stoke Therapeutics Inc

Healthcare · Biotechnology

26.10$ -10.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet STOK
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
78.3% 98.7% 98.8% 98.7% 96.0% 95.3% 94.3% 85.7% 73.1%
73.7% 98.0% 97.3% 96.4% 60.7% 44.3% 83.8% 47.1% 20.1%
73.7% 98.0% 97.3% 96.4% 92.0% 89.7% 88.2% 79.9% 68.0%
– 0.2% 0.1% 0.0% 0.1% 0.2% 0.0% 0.3% 1.9%
0.0% 0.0% – – -31.4% 4.3% – – –
19.4% 1.1% 1.1% 0.9% 3.8% 2.6% – – –
0.0% 0.0% – – – – – – –
0.0% 0.0% – – – – – – –
153.0% 2.3% 1.9% 4.0% 8.8% 27.8% 30.1% 15.7% 15.8%
152.3% 2.3% 1.8% 3.8% 7.2% 12.3% 13.5% 14.8% 13.8%
123.0% 0.0% – 0.4% 0.6% 0.9% 0.9% 0.9% 0.7%
5.8% 1.0% 0.3% 0.5% 1.0% 0.3% 0.7% 0.9% 1.2%
0.0% 0.0% – – – – – – –
-53.0% 97.7% 98.1% 96.0% 91.2% 72.2% 69.9% 84.3% 84.2%
-540.8% -23.9% -25.4% -37.0% -82.1% -116.0% -176.0% -180.7% -118.9%
964.0% 21.9% 7.9% 11.2% 15.4% 15.2% 19.3% 19.9% 14.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?